FDA Aims To Resolve OTC Labeling Issues At Three Upcoming Meetings
This article was originally published in The Tan Sheet
Executive Summary
FDA will meet with over-the-counter drug and cosmetics trade associations as many as three more times to discuss outstanding concerns regarding the OTC labeling final rule.
You may also be interested in...
P&G, Gillette First Sponsors Of MIT Auto-ID Research Center
Alternatives to UPC codes employed on retail products will be developed at a new Massachusetts Institute of Technology research center co-funded by Procter & Gamble and Gillette. The project was announced in conjunction with the recent 25th anniversary of the Universal Product Code.
OTC Labeling Exemption Requests For Ophthalmics Denied By FDA
Two requests for exemptions from certain provisions of the OTC labeling final rule are denied by FDA in Aug. 23 letters to the applicant companies.
P&G Billing Metamucil As Dual OTC/"Heart Healthy" Dietary Supplement
Procter & Gamble is changing the labeling for its psyllium-based fiber laxative Metamucil to a "dual" OTC drug and dietary fiber supplement, the firm announced Nov. 6.